FSD Pharma Inc., a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today it has entered into an agreement with Covar Pharmaceuticals Inc. (“Covar”), a contract development and manufacturing services organization (“CDMO”), to commence work on providing research quantities of FSD’s drug candidate, …Read More »
Apple, Amazon, Facebook, Tesla and Baidu are all shunning established chip firms and bringing certain aspects of chip development in-house, according to company announcements and media reports. Not content with relying on standard chips that are in high demand, some of the world’s biggest tech firms are developing their own …Read More »
Canadian business continues to anticipate a worsening inflation picture, according to a survey by an industry group. Firms expect they will raise their prices by an average 3.8 per cent over the next year, according to the August survey of members by the Canadian Federation of Independent Business, which represents …Read More »
It’s a great time to be a long-term investor. Over the past nine months, the benchmark S&P 500 hasn’t undergone a single decline of even 5%. What’s more, the index ended this past week having effectively doubled from the coronavirus crash bottom set on March 23, 2020. Yet, in spite of these …Read More »
An Ontario pharmaceutical company has become the first in Canada to receive Health Canada approval to manufacture cannabis-based prescription drugs in its facility. Burlington’s EmpowerPharm, a new clinical-stage, Canadian-owned drug company, made the announcement this week. Organic weed? See how 48North’s Good Farm is cultivating sun-grown, outdoor cannabis |… While the company was …Read More »
This story originally appeared on The Economic Times. The Haryana government has allowed reimbursement of goods and service tax paid by companies, non-governmental organisations and individuals on purchase of 15 items including Covid vaccines, remdesivir injections, ventilators and oxygen cylinders that they have donated free of cost to the state …Read More »
This story originally appeared on InvestmentNews. Financial services companies have generally adopted remote work policies, but as offices reopen, the next issue becomes who is and isn’t vaccinated. As more people receive vaccinations and local economies start to slowly reopen, the broader financial services industry is preparing for how and when to start bringing …Read More »
This story originally appeared on Cannabis & Tech today. Cannabis and innovation go hand-in-hand. From growing to packaging technology, consuming to creating, cannabis influences many innovative ideas. Innovation in cannabis isn’t always as visible as it is in other industries. Cannabis is still budding and because it’s been illegal for so …Read More »
This story originally appeared on The Fresh Toast. Despite more Americans supporting federal legalization of cannabis, many people still don’t know about the industry’s potential to harm the environment. Just like other agricultural commodities, there are environmental impacts involved when growing cannabis. But many consumers don’t know, or simply don’t care …Read More »
This story originally appeared on Investor´s Business Daily. Moderna stock posted a 66% gain in January as its coronavirus vaccine gained authorizations in a wide swath of countries, including the United States. Moderna (MRNA) joined Pfizer (PFE) and partner BioNTech (BNTX) with a Food and Drug Administration authorized Covid-19 vaccine in December. Both vaccines use …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!